Key result
No clinical study data is present in the provided text, which consists only of the journal's editorial board and masthead information.
Why the study?
Stroke severity or functional outcomes could differ according to NOAC dosing, but the impact of prior medication status, including standard-dosed versus under-dosed NOACs, remained unclear.
Does prior use of standard-dosed NOACs or therapeutic warfarin reduce initial stroke severity in patients with acute ischaemic stroke and chronic NVAF?
Does prior use of standard-dosed NOACs or therapeutic warfarin reduce initial stroke severity in patients with acute ischaemic stroke and chronic NVAF?
In patients with non-valvular atrial fibrillation who experience an acute ischemic stroke, prior treatment with standard-dose NOACs or therapeutic warfarin is associated with significantly lower initial stroke severity compared to under-dosed or no anticoagulation.
No takes yet. Share an insight, caveat, or question.
Therapeutic anticoagulation linked to milder strokes in NVAF; hypothesis-generating and should not yet change practice.
Jung et al. (2018) studied this question. No clinical study data is present in the provided text, which consists only of the journal's editorial board and masthead information.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: